SECSift

NASDAQ:TGTX

Tg Therapeutics, Inc.

Company facts

Headquarters
New York, New York
Most recent report
10-Q, filed Nov 9, 2026
Incorporated
Delaware
Filings on record
1,002+ filings
On EDGAR
CIK 1001316
Fiscal year ends
December
Filer status
Large accelerated filer

Financials 8 of 87

News 8 of 240

Prospectuses and Registrations 8 of 71

Proxies 8 of 44

Ownership 8 of 442

Other 8 of 118

Everything here comes from Tg Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.